CIK 0001534969
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
SERA PROGNOSTICS, INC.
Sign in to watch- Ticker
- SERA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 261911522
- Phone
- +1 801-990-0520
- Business address
- 2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
- Former names
- SERA PROGNOSTICS, INC.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $79,563
- in 6 filings
Net −$79,563. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-10 | Capone Mark Christopher Director | Grant or award | +42,404 | 42,404 | ||
| 2026-07-10 | Capone Mark Christopher Director | Grant or award | +1,975 | 44,379 | ||
| 2026-07-10 | Capone Mark Christopher Director | Grant or award · Stock Option (right to buy) | +62,766 | 62,766 | ||
| 2026-07-10 | Capone Mark Christopher Director | Grant or award · Stock Option (right to buy) | +3,037 | 3,037 |
Page 1 of 1 · 4 trades